Institute of Internal Medicine and Hepatology, 41447 Larissa, Greece; Department of Medicine and Research Laboratory of Internal Medicine, National Expertise Center of Greece in Autoimmune Liver Diseases, General University Hospital of Larissa, 41110 Larissa, Greece.
Department of Medicine and Research Laboratory of Internal Medicine, National Expertise Center of Greece in Autoimmune Liver Diseases, General University Hospital of Larissa, 41110 Larissa, Greece.
Eur J Intern Med. 2021 Mar;85:86-91. doi: 10.1016/j.ejim.2020.12.024. Epub 2021 Jan 12.
Differential diagnosis of autoimmune hepatitis (AIH) incorporates various liver diseases, including alcoholic liver disease (ALD). We report on clinical, laboratory and outcome characteristics of AIH patients who were initially referred as ALD based on increased alcohol consumption (AIH/ALD).
From 2000-2019, we retrospectively identified 12 AIH/ALD patients [9 males, age: 61 (30-73) years] in our prospective data base of 317 AIH patients.
AIH diagnosis was based on aminotransferases elevation in 10 patients, high IgG in 8, compatible autoantibody profile in all and typical/compatible histology in all 9 with available biopsy. There were no significant differences of baseline demographics, presentation, cirrhosis at diagnosis, response to treatment and simplified score compared to 45 age- and sex-matched AIH patients without alcohol consumption and 44 age- and sex-matched ALD patients. However, the AIH/ALD cohort was characterized by more frequent progression to cirrhosis, higher liver-related deaths and overall mortality compared to AIH, though similar to the ALD group. AST/ALT ratio>1 seems to bear a good positive (0.84) and negative predictive value (0.88) for ALD and AIH diagnosis, respectively, but cannot help in discriminating the AIH/ALD variant.
AIH should not be forgotten in patients with alcohol use when clinical and laboratory features hint towards the diagnosis of AIH/ALD variant as this group seems to have worse outcome compared to those with AIH alone suggesting the need for closer follow-up and surveillance. Reliable autoantibody testing and cautious interpretation of liver histology appear mandatory for AIH diagnosis in these difficult to diagnose cases.
自身免疫性肝炎 (AIH) 的鉴别诊断包括多种肝病,包括酒精性肝病 (ALD)。我们报告了最初因饮酒增加而被误诊为 ALD 的 AIH 患者的临床、实验室和结局特征 (AIH/ALD)。
我们回顾性地从 2000 年至 2019 年在我们前瞻性的 317 例 AIH 患者数据库中确定了 12 例 AIH/ALD 患者[9 名男性,年龄:61(30-73)岁]。
AIH 诊断基于 10 例患者的转氨酶升高,8 例患者的 IgG 升高,所有患者均具有一致的自身抗体谱,所有 9 例有肝活检的患者均具有典型/一致的组织学表现。与无饮酒史的 45 例年龄和性别匹配的 AIH 患者以及 44 例年龄和性别匹配的 ALD 患者相比,两组在基线人口统计学、表现、诊断时肝硬化、治疗反应和简化评分方面无显著差异。然而,与 AIH 相比,AIH/ALD 组更易进展为肝硬化,肝相关死亡率和总死亡率更高,尽管与 ALD 组相似。AST/ALT 比值>1 似乎对 ALD 和 AIH 的诊断具有良好的阳性(0.84)和阴性预测值(0.88),但无法帮助区分 AIH/ALD 变异型。
当临床和实验室特征提示 AIH/ALD 变异型诊断时,不应忘记患有酒精使用的患者中的 AIH,因为与单独 AIH 相比,该组患者的结局似乎更差,这表明需要更密切的随访和监测。在这些难以诊断的病例中,进行可靠的自身抗体检测和谨慎解释肝组织学似乎对 AIH 诊断至关重要。